Sun Pharma Advanced Research Company Ltd. has submitted an application to the stock exchanges seeking approval for its reclassification from the ‘Promoter Group’ category to the ‘Public’ category. This move is in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company’s request was formally lodged on August 13, 2026, following earlier intimations on July 27 and August 10, 2026.
Reclassification Application Filed
Sun Pharma Advanced Research Company Ltd. has officially applied to the National Stock Exchange of India Ltd. and BSE Limited for a significant change in its shareholding classification. The company is seeking approval to be reclassified from the ‘Promoter Group’ category to the ‘Public’ category.
Regulatory Compliance
This application is being made in strict adherence to the provisions of Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally submitted its request for no objection or approval from the stock exchanges on August 13, 2026. This action follows previous communications with the exchanges dated July 27, 2026, and August 10, 2026, regarding the intended reclassification.
Source: BSE
